Your browser doesn't support javascript.
loading
Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trials.
Sundar, Raghav; McVeigh, Terri; Dolling, David; Petruckevitch, Ann; Diamantis, Nikolaos; Ang, Joo Ern; Chenard-Poiriér, Maxime; Collins, Dearbhaile; Lim, Joline; Ameratunga, Malaka; Khan, Khurum; Kaye, Stan B; Banerji, Udai; Lopez, Juanita; George, Angela J; de Bono, Johann S; van der Graaf, Winette T.
Afiliação
  • Sundar R; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK; National University Health System, Singapore.
  • McVeigh T; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Dolling D; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Petruckevitch A; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Diamantis N; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Ang JE; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Chenard-Poiriér M; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Collins D; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Lim J; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK; National University Health System, Singapore.
  • Ameratunga M; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Khan K; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Kaye SB; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Banerji U; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Lopez J; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • George AJ; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • de Bono JS; Drug development Unit, The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • van der Graaf WT; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, UK. Electronic address: winette.vandergraaf@icr.ac.uk.
Eur J Cancer ; 101: 55-61, 2018 09.
Article em En | MEDLINE | ID: mdl-30025230

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação de Resultados em Cuidados de Saúde / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Singapura

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação de Resultados em Cuidados de Saúde / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Singapura